
### [MONDO:0016231](http://purl.obolibrary.org/obo/MONDO_0016231)
**Label:** rare capillary malformation

**Subclasses:** [MONDO:0008094](http://purl.obolibrary.org/obo/MONDO_0008094) (familial multiple nevi flammei), [MONDO:0011240](http://purl.obolibrary.org/obo/MONDO_0011240) (megalencephaly-capillary malformation-polymicrogyria syndrome), [MONDO:0010391](http://purl.obolibrary.org/obo/MONDO_0010391) (angioma serpiginosum, X-linked), [MONDO:0009055](http://purl.obolibrary.org/obo/MONDO_0009055) (cutis marmorata telangiectatica congenita (disease)), [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0017177](http://purl.obolibrary.org/obo/MONDO_0017177) (hemihyperplasia-multiple lipomatosis syndrome), [MONDO:0008501](http://purl.obolibrary.org/obo/MONDO_0008501) (Sturge-Weber syndrome), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0007115](http://purl.obolibrary.org/obo/MONDO_0007115) (angioma serpiginosum, autosomal dominant), [MONDO:0013659](http://purl.obolibrary.org/obo/MONDO_0013659) (microcephaly-capillary malformation syndrome), [MONDO:0012016](http://purl.obolibrary.org/obo/MONDO_0012016) (capillary malformation-arteriovenous malformation syndrome), [MONDO:0018719](http://purl.obolibrary.org/obo/MONDO_0018719) (rare capillary malformation with associated anomalies), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0019803](http://purl.obolibrary.org/obo/MONDO_0019803) (angioma serpiginosum), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), 

**Mapped go classes:** [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0047391](http://purl.obolibrary.org/obo/GO_0047391) (alkylglycerophosphoethanolamine phosphodiesterase activity), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0060389](http://purl.obolibrary.org/obo/GO_0060389) (pathway-restricted SMAD protein phosphorylation), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:2000811](http://purl.obolibrary.org/obo/GO_2000811) (negative regulation of anoikis), [GO:0000281](http://purl.obolibrary.org/obo/GO_0000281) (mitotic cytokinesis), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0010992](http://purl.obolibrary.org/obo/GO_0010992) (ubiquitin recycling), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:2000270](http://purl.obolibrary.org/obo/GO_2000270) (negative regulation of fibroblast apoptotic process), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0021884](http://purl.obolibrary.org/obo/GO_0021884) (forebrain neuron development), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0035005](http://purl.obolibrary.org/obo/GO_0035005) (1-phosphatidylinositol-4-phosphate 3-kinase activity), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0046934](http://purl.obolibrary.org/obo/GO_0046934) (phosphatidylinositol-4,5-bisphosphate 3-kinase activity), [GO:0045603](http://purl.obolibrary.org/obo/GO_0045603) (positive regulation of endothelial cell differentiation), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0032924](http://purl.obolibrary.org/obo/GO_0032924) (activin receptor signaling pathway), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0001508](http://purl.obolibrary.org/obo/GO_0001508) (action potential), [GO:2000279](http://purl.obolibrary.org/obo/GO_2000279) (negative regulation of DNA biosynthetic process), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0031826](http://purl.obolibrary.org/obo/GO_0031826) (type 2A serotonin receptor binding), [GO:0048696](http://purl.obolibrary.org/obo/GO_0048696) (regulation of collateral sprouting in absence of injury), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0034405](http://purl.obolibrary.org/obo/GO_0034405) (response to fluid shear stress), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0043457](http://purl.obolibrary.org/obo/GO_0043457) (regulation of cellular respiration), [GO:0045634](http://purl.obolibrary.org/obo/GO_0045634) (regulation of melanocyte differentiation), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0014067](http://purl.obolibrary.org/obo/GO_0014067) (negative regulation of phosphatidylinositol 3-kinase signaling), [GO:0014065](http://purl.obolibrary.org/obo/GO_0014065) (phosphatidylinositol 3-kinase signaling), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0070208](http://purl.obolibrary.org/obo/GO_0070208) (protein heterotrimerization), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:0032154](http://purl.obolibrary.org/obo/GO_0032154) (cleavage furrow), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:2000653](http://purl.obolibrary.org/obo/GO_2000653) (regulation of genetic imprinting), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0035412](http://purl.obolibrary.org/obo/GO_0035412) (regulation of catenin import into nucleus), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0043267](http://purl.obolibrary.org/obo/GO_0043267) (negative regulation of potassium ion transport), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0007215](http://purl.obolibrary.org/obo/GO_0007215) (glutamate receptor signaling pathway), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0005943](http://purl.obolibrary.org/obo/GO_0005943) (phosphatidylinositol 3-kinase complex, class IA), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0060158](http://purl.obolibrary.org/obo/GO_0060158) (phospholipase C-activating dopamine receptor signaling pathway), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0032757](http://purl.obolibrary.org/obo/GO_0032757) (positive regulation of interleukin-8 production), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0061036](http://purl.obolibrary.org/obo/GO_0061036) (positive regulation of cartilage development), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:0010951](http://purl.obolibrary.org/obo/GO_0010951) (negative regulation of endopeptidase activity), [GO:0007202](http://purl.obolibrary.org/obo/GO_0007202) (activation of phospholipase C activity), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0044029](http://purl.obolibrary.org/obo/GO_0044029) (hypomethylation of CpG island), [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0004843](http://purl.obolibrary.org/obo/GO_0004843) (thiol-dependent ubiquitin-specific protease activity), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), 

**Class expressions from DL-Learner:**

- Thing 55.19%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.76%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.76%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.11%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 36.11%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 36.11%


